TREATMENT AND OUTCOMES IN ANTI-HMG-COA REDUCTASE ASSOCIATED IMMUNE-MEDIATED NECROTIZING MYOPATHY – A COMPARATIVE SINGLE-CENTER COHORT STUDY AND LITERATURE REVIEW